Studies of the elevated extracellular concentration of cyclic AMP in uremic man
- PMID: 168232
- PMCID: PMC436592
- DOI: 10.1172/JCI108098
Studies of the elevated extracellular concentration of cyclic AMP in uremic man
Abstract
This study was designed to elucidate the mechanism of elevation of plasma cyclic AMP in uremic man. Plasma cyclic AMP was measured in 15 normal subjects and in 18 patients with severe renal failure. In some members from both groups the kinetic parameters of the metabolism of extracellular cyclic AMP were measured. Plasma cyclic AMP was elevated from 23 nM in control subjects to 59 nM in uremic patients, regardless of the presence or absence of the kidneys or parathyroid glands. A single pass of uremic blood through a Kiil hemodialyzer decreased plasma cyclic AMP from 58 to 30 nM. The clearance of cyclic AMP by the dialyzer correlated directly with the blood flow passing through the machine. Hemodialysis for 6 h decreased plasma cyclic AMP levels in the systemic circulation by only 12%. Studies with tritiated cyclic AMP revealed a plasma clearance rate of 624 ml/min in normal subjects and of 344 ml/min in patients with uremia. Such a large decrease in plasma clearance rate cannot be explained by a failure of urinary excretion of cyclic AMP and suggests impairment of "metabolic clearance." In addition, the "plasms production rate" of cyclic AMP was 65% higher in patients with renal failure than in normal subjects. It is concluded that the elevation of plasma cyclic AMP in uremic man is due to a combination of: (a) lack of urinary excretion, (b) decreases metabolic clearance, and (c) increased production of plasma cyclic AMP.
Similar articles
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
[Calcitonin sensitivity testing in patients with kidney diseases. Changes in serum calcium, phosphorus and plasma cyclic adenosine monophosphate levels under the effect of calcitonin in healthy subjects and uremic patients under chronic hemodialysis].Orv Hetil. 1978 May 14;119(20):1220-4. Orv Hetil. 1978. PMID: 206866 Hungarian. No abstract available.
-
Effect of salmon calcitonin on renal excretion of adenosine 3', 5' monophosphate in man.Horm Metab Res. 1976 Mar;8(2):136-40. doi: 10.1055/s-0028-1093669. Horm Metab Res. 1976. PMID: 177347
-
Red blood cell calcium homeostasis in patients with end-stage renal disease.J Lab Clin Med. 1989 Sep;114(3):222-31. J Lab Clin Med. 1989. PMID: 2527934
-
[The diagnostic value of the determination of cyclic 3',5'-adenosine monophosphate (cAMP) in urine].Quad Sclavo Diagn. 1976 Mar;12(1):15-38. Quad Sclavo Diagn. 1976. PMID: 190633 Review. Italian.
Cited by
-
Zeptomole per milliliter detection and quantification of edema factor in plasma by LC-MS/MS yields insights into toxemia and the progression of inhalation anthrax.Anal Bioanal Chem. 2019 May;411(12):2493-2509. doi: 10.1007/s00216-019-01730-4. Epub 2019 Mar 26. Anal Bioanal Chem. 2019. PMID: 30911800 Free PMC article.
-
Urinary excretion of cyclic AMP in bacterial infections.Intensive Care Med. 1979 May;5(2):73-7. doi: 10.1007/BF01686050. Intensive Care Med. 1979. PMID: 222824
-
Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.J Clin Invest. 1977 Oct;60(4):771-83. doi: 10.1172/JCI108831. J Clin Invest. 1977. PMID: 197123 Free PMC article.
-
Plasma adenosine 3':5'--cyclic monophosphate response to glucagon in uremia.Klin Wochenschr. 1982 Jul 1;60(13):651-7. doi: 10.1007/BF01716797. Klin Wochenschr. 1982. PMID: 6289001
-
Renal vein plasma adenosine 3',5'-cyclic monophosphate in renovascular hypertension.Can Med Assoc J. 1977 May 7;116(9):992-6. Can Med Assoc J. 1977. PMID: 192429 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources